Search results for " Mental Health"

showing 10 items of 3677 documents

Pathophysiologische Aspekte hirnstruktureller Veränderungen bei Morbus Fabry: Literaturübersicht

2006

Fabry Disease (FD) is a rare X-linked lysosomal storage disorder caused by deficiency of alpha-galactosidase A (alpha-GAL) enzyme activity. Neutral glycosphingolipides (esp. Gb3) accumulate in lysosomes of several tissues, particularly in vascular endothelium and smooth muscle cells. Cerebral manifestations that might be mainly due to progressive cerebrovascular dysfunction, are one major and often life-threatening burden of the disease. We reviewed the present literature concerning brain structural alterations in FD and discuss the possibly relevant underlying pathophysiological aspects of these disturbances. Cerebrovascular events (TIA, stroke) occur in FD at a rather early age. In female…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industryPhysiologyMagnetic resonance imagingDiseaseEnzyme replacement therapymedicine.diseaseFabry diseaseHyperintensityAngiopathyPsychiatry and Mental healthNeurologyInternal medicinemedicineCardiologyNeurology (clinical)businessStrokePathologicalFortschritte der Neurologie · Psychiatrie
researchProduct

1012 – Evaluation of a risk-scale for anticholinergic side-effects in elderly psychiatric inpatients

2013

Introduction Many commonly prescribed drugs have anticholinergic properties which can induce side-effects e.g. delirium, especially in an ageing brain with increased sensitivity. Risk-assessment before starting therapy may prevent such sideeffects. Objectives We rated anticholinergic pharmacological properties of prescribed medication and compared the theoretical risk with side-effects in clinical practice. Aims The scale should improve the safety of pharmacotherapy in gerontopsychiatry. Methods Based on five publications that considered anticholinergic properties of drugs, a risk-scale was established. Riskpoints for all drugs were summarized to a total score. Patients were selected from T…

medicine.medical_specialtymedicine.diagnostic_testmedicine.drug_classbusiness.industryClinical PracticePsychiatry and Mental healthPharmacotherapyTherapeutic drug monitoringmedicineAnticholinergicDeliriummedicine.symptomPsychiatryPrescribed drugsbusinessEuropean Psychiatry
researchProduct

Do Mood Stabilizers Help in Borderline Personality Disorder?

2017

BackgroundDespite the relatively weak evidence base, individuals with borderline personality disorder are often treated with pharmacological interventions. Amongst the drugs, which have shown most promise, are mood stabilizers, which were one of the two drug classes with the most beneficial effects in a previous cochrane review though the robustness of findings was described as low (Stoffers et al., 2010). Here we present data on the latest evidence for mood stabilizers based on an updated cochrane review currently underway.MethodsA systematic review and meta-analysis of randomized controlled trials was conducted. All randomized comparisons of drug vs. placebo, drug vs. drug, or drug vs. a …

medicine.medical_specialtymedicine.diseasePersonality disorderslaw.inventionPsychiatry and Mental healthMoodTolerabilityRandomized controlled triallawmedicineAnxietymedicine.symptomPsychiatryAdverse effectPsychologyBorderline personality disorderPsychopathologyClinical psychologyEuropean Psychiatry
researchProduct

Mania associated with antidepressant treatment: comprehensive meta-analytic review

2009

Tondo L, Vazquez G, Baldessarini RJ. Mania associated with antidepressant treatment: comprehensive meta-analytic review. Objective:  To review available data pertaining to risk of mania–hypomania among bipolar (BPD) and major depressive disorder (MDD) patients with vs. without exposure to antidepressant drugs (ADs) and consider effects of mood stabilizers. Method:  Computerized searching yielded 73 reports (109 trials, 114 521 adult patients); 35 were suitable for random effects meta-analysis, and multivariate-regression modeling included all available trials to test for effects of trial design, AD type, and mood-stabilizer use. Results:  The overall risk of mania with/without ADs averaged …

medicine.medical_specialtymedicine.drug_classMood stabilizermedicine.diseasebehavioral disciplines and activitiesPsychiatry and Mental healthMoodMeta-analysismental disordersmedicineMajor depressive disorderAntidepressantBipolar disorderRisk factormedicine.symptomPsychiatryPsychologyManiaActa Psychiatrica Scandinavica
researchProduct

Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systemati…

2017

Early improvement of depressive symptoms during the first two weeks of antidepressant treatment has been discussed to be a resilience signal predicting a later positive treatment outcome in patients with Major Depressive Disorder (MDD). However, the predictive value of early improvement varies between studies, and the use of different antidepressants may explain heterogeneous results. The objective of this review was to assess the predictive value of early improvement on later response and remission and to identify antidepressants with the highest chance of early improvement. We included 17 randomized controlled trials investigating early improvement in 14,779 adult patients with MDD compar…

medicine.medical_specialtymedicine.drug_classmedia_common.quotation_subjectMirtazapineTricyclic antidepressantPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineOutcome Assessment Health CaremedicineHumansPsychiatryBiological Psychiatrymedia_commonDepressive Disorder MajorResilience Psychologicalmedicine.diseaseAntidepressive Agents030227 psychiatryPsychiatry and Mental healthMeta-analysisAntidepressantMajor depressive disorderPsychological resiliencePsychology030217 neurology & neurosurgerymedicine.drugJournal of psychiatric research
researchProduct

Attention-deficit/hyperactivity disorder in adults: update on clinical presentation and care

2014

Attention-deficit/hyperactivity disorder (ADHD) is characterized by traitlike symptoms, with stable features frequently emerging in early childhood and persisting throughout adolescence and adulthood. The hallmarks are pervasive, developmentally inappropriate levels of inattention, hyperactivity and impulsivity leading to impairments in family life, social life, academic performance, and occupational functioning. Emotional lability is a commonly associated feature that is a further source of impairment. Diagnosis rests on a comprehensive assessment of developmental psychiatric history and current status, following DSM-5 guidelines on ADHD classification and diagnostic thresholds for adults.…

medicine.medical_specialtymedicine.medical_treatmentImpulsivitymedicine.diseaseFamily lifeCognitive behavioral therapyPsychiatry and Mental healthPsychiatric historyQuality of life (healthcare)medicineAttention deficit hyperactivity disorderNeurology (clinical)Effects of sleep deprivation on cognitive performanceEarly childhoodmedicine.symptomPsychiatryPsychologyClinical psychologyNeuropsychiatry
researchProduct

Pharmacotherapy of Borderline Personality Disorder: A Metaanalysis of Randomised Controlled Trials

2009

Background:In Borderline Personality Disorder (BPD), pharmacotherapy is used for the treatment of specific BPD pathology facets, such as cognitive-perceptual, affective, or impulsivity symptoms. Due to the polymorphic phenomenology of the disorder, different classes of drugs are used, e.g., antipsychotics, antidepressants, or mood stabilizers.Aims:To evaluate the up-to-date evidence of drug treatment efficacy for BPD.Method:A systematic review and metaanalysis of randomised controlled trials was done. All randomised comparisons of drug vs. placebo, drug vs. drug, or drug vs. a combination of drugs in adult BPD patients were eligible for inclusion. Outcomes comprised BPD core pathology as de…

medicine.medical_specialtymedicine.medical_treatmentImpulsivitymedicine.diseasePsychiatry and Mental healthMoodTolerabilitymedicineAnxietymedicine.symptomAdverse effectPsychiatryAntipsychoticPsychologyBorderline personality disorderPsychopathologyClinical psychologyEuropean Psychiatry
researchProduct

Group psychoeducation with relaxation for severe fear of childbirth improves maternal adjustment and childbirth experience – a randomised controlled …

2014

Previous studies on the treatment of women with fear of childbirth have focused on the delivery mode. Women with fear of childbirth often suffer from anxiety and/or depression, and treatment therefore also needs to target postnatal psychological well-being and the early mother-infant relationship.Three hundred and seventy-one nulliparous women out of 4575 scored ≥100 in prospective screening (Wijma Delivery Expectancy Questionnaire, W-DEQ-A), indicating severe fear of childbirth. These women were randomised to psychoeducative group intervention with relaxation (n = 131; six sessions during pregnancy, one postnatal) or to conventional care (n = 240) by community nurses (referral if necessary…

medicine.medical_specialtymedicine.medical_treatmentMothersRelaxation TherapyPatient Education as TopicPregnancySurveys and QuestionnairesAdaptation PsychologicalPsychoeducationmedicineHumansChildbirthPsychiatryta515Pregnancybusiness.industryPostpartum PeriodParturitionSocial SupportObstetrics and GynecologyFearMaternal adjustmentChildbirth experienceDelivery ObstetricDelivery modemedicine.diseaseta3123Postnatal depressionPregnancy ComplicationsPsychiatry and Mental healthClinical PsychologyPost traumatic stress syndromeReproductive MedicineFear of childbirthEdinburgh Postnatal Depression ScalePsychotherapy GroupAnxietyFemalePregnant Womenmedicine.symptombusinessPsychosocialPostpartum periodJournal of Psychosomatic Obstetrics & Gynecology
researchProduct

Transcranial magnetic stimulation as therapy for depression and other disorders.

1997

Objective: To provide an overview of the progress and prospects of transcranial magnetic stimulation as a psychiatric therapy for depression. Method: Published and unpublished studies of the usefulness of transcranial magnetic stimulation as a therapy for depression were assessed, and characterised in terms of a consistent measure of dosage. Additional information was obtained through correspondence, personal meetings and visits to facilities. Results: Transcranial magnetic stimulation, a means for inducing small regional currents in the brain, has been used in clinical neurology for some time, and can be used on conscious subjects with minimal side-effects. Early researchers noticed trans…

medicine.medical_specialtymedicine.medical_treatmentStimulation03 medical and health sciences0302 clinical medicineElectroconvulsive therapyPhysical medicine and rehabilitationmedicineHumans030212 general & internal medicineDeep transcranial magnetic stimulationPsychiatryElectroconvulsive TherapyDepression (differential diagnoses)Depressive DisorderGeneral Medicinemedicine.diseaseTranscranial Magnetic Stimulation030227 psychiatryClinical neurologyTranscranial magnetic stimulationPsychiatry and Mental healthMoodSchizophreniaSchizophreniaPsychologyhuman activitiesThe Australian and New Zealand journal of psychiatry
researchProduct

Immediate Effects of Anodal Transcranial Direct Current Stimulation on Postural Stability Using Computerized Dynamic Posturography in People With Chr…

2020

Postural stability is commonly decreased in individuals with chronic post-stroke hemiparesis due to multisystemic deficits. Transcranial direct current stimulation (tDCS) is a non-invasive method to modulate cortical excitability, inducing neuroplastic changes to the targeted cortical areas and has been suggested to potentially improve motor functions in individuals with neurological impairments. The purpose of this double-blinded, sham-controlled study was to examine the acute effects of anodal tDCS over the lesioned motor cortex leg area with concurrent limits of stability training on postural control in individuals with chronic post-stroke hemiparesis. Ten individuals with chronic post-s…

medicine.medical_specialtymedicine.medical_treatmentpostural controlFear of falling050105 experimental psychologylcsh:RC321-57103 medical and health sciencesBehavioral Neuroscience0302 clinical medicinePhysical medicine and rehabilitationcenter of gravitymedicine0501 psychology and cognitive sciencesfear of fallinglcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBiological PsychiatryBalance (ability)Original Researchpost-stroke hemiparesisRehabilitationTranscranial direct-current stimulationdynamic posturographybusiness.industry05 social sciencesPosturographyPsychiatry and Mental healthHemiparesismedicine.anatomical_structureNeuropsychology and Physiological PsychologyNeurologyBerg Balance Scalemedicine.symptomtranscranial direct current stimulationbusiness030217 neurology & neurosurgeryMotor cortexNeuroscienceFrontiers in Human Neuroscience
researchProduct